Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Medicines Co (NASDAQ:MDCO)

39.58
Delayed Data
As of 3:59pm ET
 +1.13 / +2.94%
Today’s Change
27.50
Today|||52-Week Range
43.79
+6.00%
Year-to-Date
Alnylam Pharmaceuticals, Inc. Cranks Out the Data
Aug 12 / MotleyFool.com - Paid Partner Content
Mallinckrodt (MNK) to Buy Stratatech for Undisclosed Value
Aug 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close38.45
Today’s open38.50
Day’s range38.47 - 39.94
Volume1,048,504
Average volume (3 months)984,148
Market cap$2.7B
Dividend yield--
Data as of 3:59pm ET, 08/23/2016

Growth & Valuation

Earnings growth (last year)-956.00%
Earnings growth (this year)+63.39%
Earnings growth (next 5 years)+72.90%
Revenue growth (last year)-57.34%
P/E ratioNM
Price/Sales8.07
Price/Book3.65

Competitors

 Today’s
change
Today’s
% change
RAREUltragenyx Pharmaceu...+1.26+1.85%
PBHPrestige Brands Hold...+0.25+0.52%
GLPGGalapagos NV+0.59+1.08%
CBPOChina Biologic Produ...-0.38-0.33%
Data as of 4:02pm ET, 08/23/2016

Financials

Next reporting dateOctober 19, 2016
EPS forecast (this quarter)-$1.31
Annual revenue (last year)$309.0M
Annual profit (last year)-$352.8M
Net profit margin-71.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Clive A. Meanwell
President &
Chief Operating Officer
Stuart Anthony Kingsley
Corporate headquarters
Parsippany, New Jersey

Forecasts

Partner Offers

Search for Jobs